See every side of every news story
Published loading...Updated

Stephen Saads Wealth Takes A Hit As Aspen Pharmacare Stock Plunges Erasing 41 Million : The Africa

Summary by theafrica.co.za
Aspen Pharmacares stock slid 7.27% in 55 days, wiping R750.75 million ($41.15 million) from CEO Stephen Saads stake. Aspens first-half revenue rose 3.87% to $1.2 billion, while profit climbed 3.2% to
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Billionaires.Africa broke the news in on Thursday, March 27, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.